Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Next Generation Sequencing Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The next generation sequencing market has experienced swift expansion recently. This market is projected to expand from $14.2 billion in 2025 to $16.31 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.9%. Historically, this expansion has been driven by several factors, including heightened research efforts in genomics, reduced expenses for sequencing technologies, the proliferation of molecular diagnostics laboratories, a surge in demand for genetic analysis linked to diseases, and the widespread availability of advanced sequencing reagents.
The next generation sequencing market size is anticipated to expand rapidly in the coming years, with projections indicating it will reach $28.59 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 15.1%. This growth during the forecast period can be primarily attributed to the increasing adoption of precision medicine initiatives, a rise in investments allocated to population genomics studies, the broadening application of NGS in oncology diagnostics, a growing demand for prompt sequencing solutions, and the increasing integration of sequencing data with clinical decision systems. Key trends expected throughout this period encompass the greater adoption of high-throughput sequencing platforms, a rising need for clinical diagnostic sequencing, the expanding integration of AI-based bioinformatics tools, the wider application of targeted and personalized medicine, and an enhanced emphasis on cost-effective sequencing workflows.
Get A Free Sample Report With In-Depth Market Insights:
Next Generation Sequencing Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The next-generation sequencing market is anticipated to expand due to the rising demand for personalized medicine moving forward. Often called precision medicine, personalized medicine represents an innovative medical and healthcare strategy that customizes treatment decisions and therapies by considering a person’s distinct genetic makeup, environmental influences, and lifestyle choices. As a fundamental technology within personalized medicine, next-generation sequencing facilitates accurate evaluation of an individual’s genetic profile and supports the creation of customized healthcare plans. An example illustrating this trend is that in February 2024, the Personalised Medicine Coalition, a US-based hospital and health care organization, reported that the FDA approved 16 novel personalized treatments for rare disease patients in 2023, an increase from 6 approvals in 2022. Consequently, the expanding need for personalized medicine is fueling the growth of the next-generation sequencing market.
Next Generation Sequencing Market Segment Performance And Emerging Opportunities
The next generation sequencing market covered in this report is segmented –
1) By Product: Instruments, Reagents And Kits, Software
2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing, Other Sequencing Technologies
3) By Application: Diagnostics, Drug Discovery, Other Applications
Subsegments:
1) By Instruments: Sequencing Systems, Library Preparation Instruments, Quality Control Instruments
2) By Reagents And Kits: Sequencing Reagents, Library Preparation Kits, Amplification Kits
3) By Software: Data Analysis Software, Bioinformatics Software, Workflow Management Software
Next Generation Sequencing Market Innovation Trends Shaping Future Development
Major companies operating in the next-generation sequencing market are prioritizing the development of advanced solutions like hybrid long- and short-read sequencing to boost genomic resolution and accuracy. This approach combines the high throughput and low error rates of short reads with the structural insight and coverage advantages of long reads. For instance, in March 2023, Illumina, a US-based biotechnology company, launched the Illumina Complete Long Read Prep, Human assay, featuring its innovative Complete Long Read technology. This assay facilitates the generation of both long- and short-read data on the same Illumina instrument and is specifically designed for compatibility with NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 systems. Its prominent features encompass a simplified workflow with substantially reduced DNA input requirements compared to other long read platforms, the integration of Illumina sequencing-by-synthesis (SBS) chemistry with DRAGEN secondary analysis for highly accurate whole-genome sequencing, the capability to access hard to map and challenging genic regions, and a promotional price of US $1,350 per genome (on NovaSeq X Plus with a 25B flow cell), which includes long- and short-read library preparation, sequencing, and cloud analysis.
Next Generation Sequencing Market Top Companies Driving Competitive Growth
Major companies operating in the next generation sequencing market are Illumina Inc, Thermo Fisher Scientific Inc, Pacific Biosciences of California Inc, Oxford Nanopore Technologies Ltd, QIAGEN NV, Agilent Technologies Inc, PerkinElmer Inc, BGI Group, 10x Genomics Inc, Takara Bio Inc, New England Biolabs Inc, Twist Bioscience Corp, Element Biosciences Inc, Ultima Genomics Inc, SeqWell Inc, Integrated DNA Technologies Inc, LGC Limited, Bio-Rad Laboratories Inc, Zymo Research Corporation, NimaGen BV
View The Full Next Generation Sequencing Market Report:
Next Generation Sequencing Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the next generation sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next generation sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
